Fluor Corp. has started construction for Bayer AG’s first-of-a-kind cell culture technology center in Berkeley.
Fluor is providing engineering, procurement, construction management and commissioning, qualification and validation services for the facility that will produce oncology and other therapeutics.
The state-of-the-art, single-use technology (SUT) biopharmaceutical manufacturing center will be constructed at Bayer’s Berkeley site using land from a demolished office building.
In 2018, Fluor engaged in the conceptual study and front-end engineering design for the project which is due for completion in early 2021.
Bayer selected GE Healthcare to provide its FlexFactory SUT platform which will be incorporated into the project through a collaborative subcontract to Fluor. GE Healthcare is supplying all major unit operations, systems and ancillary equipment and components.
Fluor’s scope also includes process integration for the entire facility and all associated utilities. The company’s San Francisco office will lead the project with support from the company’s offices in Greenville, South Carolina and Gliwice, Poland.
While $6.7 million are going to Bergen Place in the Village of Freeport. The development will create 45 senior and supportive homes. 14 apartments will be reserved for formerly homeless frail or elderly seniors.
